UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 479

Sortiert nach

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

Haematologica (Roma), 2021-04, Vol.106 (4), p.978

2021

Volltextzugriff (PDF)

Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2021-12, Vol.56 (12), p.2897-2903

2021

Volltextzugriff (PDF)

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2018-05, Vol.53 (5), p.535-555

2018

Volltextzugriff (PDF)

Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide

Bone marrow transplantation (Basingstoke), 2021-07, Vol.56 (7), p.1683-1690

2021

Volltextzugriff (PDF)

Improved survival after acute graft- versus -host disease diagnosis in the modern era

Haematologica (Roma), 2017-05, Vol.102 (5), p.958

2017

Volltextzugriff (PDF)

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis

Haematologica (Roma), 2023-01, Vol.108 (1), p.150

2023

Volltextzugriff (PDF)

Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study

British journal of haematology, 2017-12, Vol.179 (5), p.781-789

2017

Volltextzugriff (PDF)

A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma

Cancer, 2015-10, Vol.121 (20), p.3622-3630

2015

Volltextzugriff (PDF)

A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients

Bone marrow transplantation (Basingstoke), 2022-02, Vol.57 (2), p.295-298

2022

Volltextzugriff (PDF)

Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study

Bone marrow transplantation (Basingstoke), 2019-08, Vol.54 (8), p.1354-1360

2019

Volltextzugriff (PDF)

Pediatric‐inspired therapy compared to allografting for Philadelphia chromosome‐negative adult ALL in first complete remission

American journal of hematology, 2016-03, Vol.91 (3), p.322-329

2016

Volltextzugriff (PDF)

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation

Haematologica (Roma), 2017-05, Vol.102 (5), p.948

2017

Volltextzugriff (PDF)

Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis

Bone marrow transplantation (Basingstoke), 2022-01, Vol.57 (1), p.31-37

2022

Volltextzugriff (PDF)

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

Haematologica (Roma), 2012-12, Vol.97 (12), p.1882-1889

2012

Volltextzugriff (PDF)

Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review

International journal of genomics, 2017-01, Vol.2017, p.1-6

2017

Volltextzugriff (PDF)

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality

Haematologica (Roma), 2011-11, Vol.96 (11), p.1678-1684

2011

Volltextzugriff (PDF)

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia

Blood advances, 2019-02, Vol.3 (4), p.670-680

2019

Volltextzugriff (PDF)

In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation

Haematologica (Roma), 2018-03, Vol.103 (3), p.531

2018

Volltextzugriff (PDF)

Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel

Cancers, 2023-09, Vol.15 (19), p.4711

2023

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis

Journal of hematology and oncology, 2019-01, Vol.12 (1), p.6-6, Article 6

2019

Volltextzugriff (PDF)

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment

Current hematologic malignancy reports, 2016-04, Vol.11 (2), p.118-126

2016

Volltextzugriff (PDF)

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

Journal of hematology and oncology, 2013-01, Vol.6 (1), p.2-2, Article 2

2013

Volltextzugriff (PDF)

Role of hematopoietic cell transplantation in relapsed acute promyelocytic leukemia

Clinical transplantation, 2020-09, Vol.34 (9), p.e14009-n/a

2020

Volltextzugriff (PDF)

1 – 25 von 479

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(378)
Mit Volltextzugriff
(456)

Publikationsform

Sprache

Englisch
(479)
Japanisch
(34)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(213)
Science & Technology
(213)
Humans
(173)
Hematology
(172)
Transplantation
(129)
Immunology
(93)
Middle Aged
(89)
Adult
(86)
Male
(81)
Female
(79)
Aged
(73)
Oncology
(71)
Medicin Och Hälsovetenskap
(59)
Hematology, Oncology And Palliative Medicine
(54)
Retrospective Studies
(54)
Hematopoietic Stem Cell Transplantation
(53)
Transplantation, Homologous
(50)
Hematopoietic Stem Cell Transplantation - Methods
(49)
Young Adult
(41)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide

Improved survival after acute graft- versus -host disease diagnosis in the modern era

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis

Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study

A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma

A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients

Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study

Pediatric‐inspired therapy compared to allografting for Philadelphia chromosome‐negative adult ALL in first complete remission

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation

Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia

In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation

Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis

Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

Role of hematopoietic cell transplantation in relapsed acute promyelocytic leukemia

Suchergebnisse filtern